健康产业运营

Search documents
股票行情快报:尚荣医疗(002551)8月18日主力资金净卖出1.10亿元
Sou Hu Cai Jing· 2025-08-18 13:47
Core Viewpoint - The stock of Shangrong Medical (002551) has shown a price increase of 4.52% as of August 18, 2025, closing at 5.09 yuan, with significant trading activity and mixed capital flows [1][2]. Financial Performance - Shangrong Medical reported a total revenue of 280 million yuan for Q1 2025, reflecting a year-on-year increase of 1.3% [3]. - The net profit attributable to shareholders was 13.96 million yuan, up 0.58% year-on-year, while the non-recurring net profit surged by 84.75% to 11.70 million yuan [3]. - The company's debt ratio stands at 22.29%, with investment income of 2.96 million yuan and financial expenses of -6.64 million yuan [3]. Market Position - Shangrong Medical's total market capitalization is 4.304 billion yuan, significantly lower than the industry average of 12.121 billion yuan, ranking 87 out of 123 in the medical device sector [3]. - The company has a net asset value of 2.789 billion yuan, compared to the industry average of 3.9 billion yuan, ranking 54 out of 123 [3]. - The company's gross margin is 15.27%, which is substantially below the industry average of 51.35%, ranking 119 out of 123 [3]. Capital Flow Analysis - On August 18, 2025, the net outflow of main funds was 110 million yuan, accounting for 11.15% of the total trading volume, while retail investors saw a net inflow of 81.24 million yuan, representing 8.27% of the total [1][2]. - Over the past five days, the stock has experienced fluctuations in capital flow, with notable changes in the net inflow and outflow of main and retail funds [2].
尚荣医疗(002551)8月6日主力资金净卖出1637.77万元
Sou Hu Cai Jing· 2025-08-06 07:45
| | | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净点比 游资净占比 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-08-06 | 3.84 | -2.29% | -1637.77万 | -14.09% | 244.64万 | 2.10% | 1393.13万 | 11.98% | | 2025-08-05 | | 3.93 -0.51% | -2759.42万 | -22.83% | 719.22万 | 5.95% | 2040.19万 | 16.88% | | 2025-08-04 | 3.95 | 1.28% | 204.79万 | 1.62% | -88.43万 | -0.70% | -116.37万 | -0.92% | | 2025-08-01 | 3.90 | 2.90% | 2700.54万 | 18.24% | -892.84万 | -6.03% | -1807.70万 | -12.21% | | 2025-07-31 | 3.79 -0.79% | | -18 ...
尚荣医疗收盘上涨2.57%,滚动市盈率150.86倍,总市值33.74亿元
Sou Hu Cai Jing· 2025-07-07 08:59
Group 1 - The core viewpoint of the articles highlights the performance and valuation of Shangrong Medical, which has a current PE ratio of 150.86, significantly higher than the industry average of 51.42 [1][2] - As of July 7, Shangrong Medical's stock closed at 3.99 yuan, marking a 2.57% increase, with a total market capitalization of 3.374 billion yuan [1] - The company has seen a net inflow of 10.55 million yuan in principal funds on July 7, with a total inflow of 9.69 million yuan over the past five days [1] Group 2 - Shangrong Medical reported a revenue of 280 million yuan for Q1 2025, reflecting a year-on-year increase of 30% [2] - The net profit for the same period was 13.96 million yuan, showing a year-on-year growth of 0.58%, with a sales gross margin of 15.27% [2] - The company is recognized as a national high-tech enterprise and has accumulated over 180 patents, which contribute to its ongoing development [1]